Skip to content
About Us
Transactions
Practice Areas
Professionals
Resources
Firm News
Client Alerts
Client Portal
pra mergers acquisitions
ContraVir Pharmaceuticals Announces $9.0 Million Private Placement
May 6, 2020
CEL-SCI Corporation Announces $6.0 Million Public Offering
May 6, 2020
Towerstream Corporation Announces $35.0 Million Secured Financing
May 6, 2020
Sichenzia Ross Friedman Ference LLP Advises Single Touch on a $11.0 M Debt and Equity Financing Consisting of a $10.0 M Secured Financing and a $1.0 M PIPE with Fortress Investment Group
May 6, 2020
Sichenzia Ross Friedman Ference LLP Advises Rightscorp, Inc. on a $2.65M PIPE Offering
May 6, 2020
Sichenzia Ross Friedman Ference LLP Advises Citius Pharmaceuticals, LLC on a Reverse Merger and $2.04 Million Pipe Financing
May 6, 2020
Sichenzia Ross Friedman Ference LLP Advises Labor Smart, Inc. on a $1.1 million Private Placement of Common Stock.
May 6, 2020
Sichenzia Ross Friedman Ference LLP Advises Intellect Neurosciences, Inc. on $1.2 Million PIPE offering
May 6, 2020
Sichenzia Ross Friedman Ference LLP Advises Tonix Pharmaceuticals on $7.8 Million Public Offering
May 6, 2020
Sichenzia Ross Friedman Ference LLP Advises J.P. Turner & Company on $2.1 Million Private Placement for Nanox Imaging PLC
May 6, 2020
Sicheniza Ross Friedman Ference Advises Cell Source Ltd. on Reverse Merger
May 6, 2020
CollabRx, Inc.
May 6, 2020
Sichenzia Ross Friedman Ference LLP Advises NTS Inc. on $140.0 Million Acquisition Transaction
May 6, 2020
Sichenzia Ross Friedman Ference LLP Advises FreeSeas Inc. on $25.0 Million Public Offering of Preferred Stock and Warrants
May 6, 2020
Sichenzia Ross Friedman Ference LLP Advises Zenovia Digital Exchange Corp. on $5 Million Private Placement Transaction
May 6, 2020
Sichenzia Ross Friedman Ference LLP Advises Vuzix Corporation on a $3 Million PIPE Offering
May 6, 2020
Sichenzia Ross Friedman Ference LLP Advises Sorrento Therapeutics, Inc. on $25.0 million Public Offering of Common Stock
May 6, 2020
Sichenzia Ross Friedman Ference LLP Advises Laidlaw & Company on $10 million Secondary Public Offering of Cyclacel Pharmaceuticals, Inc.
May 6, 2020
Sichenzia Ross Friedman Ference LLP Advises Laidlaw & Company on $6.72 million Secondary Public Offering of Novabay Pharmaceuticals, Inc.
May 6, 2020
Sichenzia Ross Friedman Ference LLP Advises Laidlaw & Company on $10 million Private Placement of Relmada Therapeutics, Inc.
May 6, 2020
Sichenzia Ross Friedman Ference LLP Advises AV Therapeutics, Inc. on $1.26 million PIPE Offering
May 6, 2020
« Previous
1
…
37
38
39
40
41
…
74
Next »
